Oh really... Nov 26,2024 Anavex Life Sciences Announces Submission of Blarcamesine MAA for Treatment of Alzheimer’s Disease to EMA and then there's this little beauty Dec 23,2024 Blarcamesine Receives EMA Filing Acceptance for Treatment of Alzheimer’s Disease. Just to name a couple..